Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
The U.S. Food and Drug Administration, along with its National Antimicrobial Resistance Monitoring System partners, the Centers for Disease Control and Prevention & the United States Department of Agriculture, will be holding the 2017 Scientific Meeting of the National Antimicrobial Resistance Monitoring System (NARMS). The purpose of this public meeting will be to summarize NARMS progress since the last public meeting in 2014, present recommendations made by the recent FDA Science Board review of NARMS in 2017, and to explore new possible directions for NARMS within a One Health paradigm.
The public meeting will be held on Tuesday, October 24 and Wednesday, October 25, 2017, from 8:30 a.m. to 5:00 p.m. at the U.S. Department of Agriculture’s South Building, in the Jefferson Auditorium, 14th & Independence Avenue SW, Washington, DC 20250.